|
|
|
|
Drug Companies Withholding Results of Pediatric Studies
Washington,
Jul 20, 2004 -
Rep. Waxman writes HHS to express concern about the pharmaceutical industry’s withholding of the results of clinical trials involving children, despite the extremely valuable six months of exclusive marketing that drug companies are granted in exchange for conducting such studies.
|
Print version of this document
|